Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1619-1628

  Cowan, Kenneth H ^a,f   Moscow, Jeffrey A ^a   Huang, Hui ^a   Zujewski, Jo Anne ^a   O'Shaughnessy, Joyce ^a   Sorrentino, Brian ^d   Hines, Kenneth ^c   Carter, Charles ^c   Schneider, Erasmus ^a   Cusack, Georgie ^a   Noone, Marianne ^a   Dunbar, Cynthia ^b   Steinberg, Seth ^a   Wilson, Wyndham ^a   Goldspiel, Barrie ^c   Read, Elizabeth J ^c   Leitman, Susan F ^c   McDonagh, Kevin ^b   Chow, Catherine ^c   Abati, Andrea ^a   Chiang, Yu ^e   Chang, Yawen N ^e   Gottesman, Michael M ^a   Pastan, Ira ^a   Nienhuis, Arthur ^d   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MESNA; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VIRUS VECTOR;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; GENE TARGETING; HEMATOPOIESIS; HUMAN; METASTASIS POTENTIAL; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; TRANSGENE;

ADULT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DNA, COMPLEMENTARY; DRUG TOXICITY; FEMALE; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; P-GLYCOPROTEIN; PACLITAXEL; PILOT PROJECTS; POLYMERASE CHAIN REACTION; RETROVIRIDAE; T-LYMPHOCYTE SUBSETS; TRANSDUCTION, GENETIC; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032809319     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Dunbar, C. E., Cottler-Fox, M., O'Shaughnessy, J. A., Doren, S. A., Carter, C. S., Berenson, R., Brown, S., Moen, R., Greenblatt, J., Stewart, F. M., Leitman, S. F., Wilson, W., Cowan, K. H., Young, N. S., and Nienhuis, A. W. Retrovirally marked CD34+-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood, 85: 3048-3057, 1995.
2. Emmons, R. V. B., Doren, S., Zujewski, J., Cottler-Fox, M., Carter, C. S., Hines, K., O'Shaughnessy, J., Leitman, S. F., Cowan, K., and Dunbar, C. E. Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood, 89: 4040-4046, 1996.
3. Brenner, M. K., Rill, D. R., and Holladay, M. S. Gene marking to determine whether autologous marrow infusion restores long term haemopoiesis in cancer patients. Lancet, 342: 1134-1137, 1993.
4. Brenner, M. K., Rill, D. R., and Moen, R. C. Gene-Marking to trace origin of relapse after autologous bone marrow transplantation. Lancet, 15: 1-18, 1993.
5. Antman, K. H., Rowlings, P. A., Vaughan, W. P., Pelz, C. J., Fay, J. W., Fields, K. K., Freytes, C. O., Gale, R. P., Hillner, B. E., Holland, H. K., Kennedy, M. J., Klein, J. P., Lazarus, H. M., McCarthy, P. L., Jr, Saez, R., Spitzer, G, Stadtmauer, E. A., Williams, S. F., Wolff, S., Sobocinski, K. A., Armitage, J. O., and Horowitz, M. M. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J. Clin. Oncol., 15: 1870-18789, 1997.
6. Peters, W. P., Ross, M., Vredenburgh, J. J., Meisenberg, B., Marks, L. B., Winer, E, Kurtzberg, J., Bast, R. C. J., Jones, R., Shpall, E., Wu, K., Rosner, G., Gilbert, C., Mathias, B., Coniglio, D., Petros, W., Henderson, I. C., Norton, L., Weiss, R. B., Budman, D., and Hurd, D. High-dose chemotherapy and autologous bone marrow support as consolidation after standard dose adjuvant therapy for high-risk primary breast cancer. J. Clin. Oncol., 11: 1132-1143, 1993.
7. Mickisch, G. H., Merlino, G. T., Galski, H., Gottesman, M. M., and Pastan, I. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc. Natl. Acad. Sci. USA, 88: 547-551, 1991.
8. Mickisch, G. H., Licht, T., Merlino, G. T., Gottesman, M. M., and Pastan, I. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity. Cancer Res, 51: 5417-5425, 1991.
9. Mickisch, G. H., Aksentijevich, I., Schoenlein, P. V., Goldstein, L. J, Galski, H., Stahle, C., Sachs, D. H., Pastan, I., and Gottesman, M. M. Transplantation of bone marrow cells from transgenic mice expressing the human mdr1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice. Blood, 79: 1087-1093, 1992.
10. Sorrentino, B., Brandt, S. J., Bodine, D., Gottesman, M., Pastan, I., Cline, A., and Nienhuis, A. W. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science (Washington DC), 257: 99-103, 1992.
11. Hanania, E. G., Fu, S., Roninson, I., Zu, Z., Gottesman, M. M., and Deisseroth, A. B. Resistance to Taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit. Gene Ther., 2: 279-284, 1995.
12. Richardson, C., and Bank, A. Preselection of transduced murine hematopoietic stem cell populations leads to increased long-term stability and expression of the human multiple drug resistance gene. Blood, 86: 2579-2589, 1995.
13. Podda, S., Ward, M., Himelstein, A., Richardson, C. Dela Flor-Weiss, E., Smith, L., Gottesman, M., Pastan, I., and Bank, A. Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. USA, 89: 9676-9680, 1992.
14. McLachlin, J. R., Mitterder, N., Daucher, M. B., Kadan, M., and Eglitis, M. A. Factors affecting retroviral vector function and structural integration. Virology, 195: 1-5, 1993.
15. Sorrentino, B. P., McDonagh, K., Woods, D., and Orlic, D. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice. Blood, 86: 491-501, 1995.
16. Miller, A. D., and Buttmore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol., 6: 2895-2902, 1986.
17. Wilson, W. H., Jain, V., Bryant, G., Cowan, K. H., Carter, C., Cottler-Fox, M., Goldspiel, B., Steinberg, S. M., Longo, D. L., and Wittes, R. E. Phase I, and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors. J. Clin. Oncol., 10: 1712-1722, 1992.
18. Berenson, R. J., Bensinger, W. I., Hill, R. S., Andrew, R. G., Garcia, L. J., Kalamasz, D. F., Still, B. J., Spitzer, G., Buckner, C. D., Bernstein, I. D., and Thomas, E. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood, 77: 1717-1722, 1991.
19. Chen, C. J., Clark, D., Ueda, K., Pastan, I., Gottesman, M. M., and Roninson, I. B. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J. Biol. Chem., 265: 506-514, 1990.
20. Cornetta, K., Morgan, R. A., and Anderson, W. F. Safety Issues related to retroviral gene transfer to humans. Hum. Gene Ther., 2: 5-14, 1991.
21. Hanania, E. G., Giles, R. E., Kavanagh, J., Ellerson, D. Zu, Z., Wang, T., Su, Y, Kudelka, A., Rahman, Z., Holmes, F., Hortobagyi, G., Claxton, D., Bachier, C., Thall, P., Cheng, S., Hester, J., Ostrove, J. M., Bird, R. E., Chang, A., Korbling, M., Seong, D. Cote, R., Holzmayer, T., Mechetner, E., Heimfeld, S., Berenson, R., Burtness, B., Edwards, C., Bast, R., Andreeff, M., Champlin, R., and Deisseroth, A. B. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc. Natl. Acad. Sci. USA, 93: 15346-15351, 1996.
22. Hesdorfer, C., Ayello, J., Ward, M. A. K., Vahdat, L., Balmaceda, C., Garrett, T., Fetell, M., Reiss, R., Bank, A., and Antman, K. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapty in autologous stem-cell transplantation. J. Clin. Oncol., 16: 165-172, 1998.
23. Bunting, K. D., Galipeau, J., Topham, D., Benaim, E., and Sorrentino, B. P. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo expansion, but these grafts cause a myeloproliferative syndrome in transplanted mice. Blood, in press, 1999.
24. Robinson, L. J., Roberts, W. K., Ling, T. T., Lamming, D., Sternberg, S. S., and Roepe, P. D. Human Mdr 1 protein overexpresson delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry, 36: 507, 1997.
25. Bezombes, C., Maestre, N., Laurent, G., Levade, T., Bettaib, A., and Jaffrezou, J. P. Restoration of TNF-α-induced ceramide generation in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC388. FASEB J., 12: 101, 1998.
26. Hanania, E. G., and Deisseroth, A. B. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model. Cancer Gene Ther, 1: 21-25, 1994.
27. Rahman, Z., Kavanagh, J., Champlin, R., Giles, R. Hanania, E., Fu, S. Q., Zu, Z. F., Mehra, R., Holmes, F., Kudelka, A., Claxton, D., Verschraegen, C., Gajewski, J., Andreeff, M., Heimfeld, S., Berenson, R., Ellerson, D., Calvert, L., Mechetner, E., Holzmayer, T., Dayne, A., Hamer, J., Bachier, C., Ostrove, J., Przepiorka, D., Burtness, B., Cote, R., Bast, R., Hortobagyi, G., and Deisseroth, A. Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer. Clinical Cancer Res., 4: 2717-2721, 1998.
28. Peters, S. O., Kittler, E. L. W., Ramshaw, H. S., and Quesenberry, P. J. Ex-vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood, 87: 30-37, 1996.
29. Zhao, S-C., Li, M-X., Banerjee, D., Schweitzer, S., Moneishi, S., Gilboa, E., and Bertino, J. R. Long term engraftment of recipient mice from lethal doses of methotrexate by marrow infected with a double copy vector retrovirus containing a mutant dihydrofolate reductase. Cancer Gene Therapy, 1: 27-33, 1994.
30. Flassove, M., Banerjee, D., Mineishi, S., Li, M-X., Bertino, J. R., and Moore, A. S. Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydofolate reductase cDNA via retroviral transfer. Blood, 85: 566-574, 1995.
31. Spencer, H., Sleep, S. E. H., Rehg, J. E., Blakely, R. L., and Sorrentino, B. P. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood, 87: 2579-2587, 1996.
32. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res., 15: 5093-5099, 1997.
33. Maze, R., Carney, J. P., Kelley, M. R., Glassner, B. J., Williams, D. A., and Samson, L. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescuses mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc. Nat. Acad. Sci. USA, 9: 206-210, 1996.
34. Corey, C. A., Deolva, A. D., Holland, C. A., and Williams, D. A. Serial transplantation of methotrexate-resistant bone marrow: protection from drug toxicity by progeny of transduced stem cells. Blood, 75: 337, 1990.
35. Williams, D. A., Hsieh, K., DeSilva, A. D., and Mulligen, R. C. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J. Exp. Med., 166: 210, 1987.
36. Magni, M., Hammah, S., Schiro, R. Mellado, W., Dalla-Favera, R., and Gianni, A. M. Induction of cylcophosphamide resistance by aldehyde dehydrogenase gene transfer. Blood, 87: 1097-1103, 1996.
37. 6benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea. Proc. Natl. Acad. Sci. USA, 93: 14088-14093, 1996.
38. Allay, J. A., Dumenco, L. L., Koc, O. N., Liu, L., and Gerson, S. L. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood, 85: 3342-3351, 1995.
39. Allay, J. A., Davis, B. M., and Gerson, S. L. Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice. Exp. Hematol. (Charlottesv.), 25: 1069-1076, 1997.
40. Dunbar, C., Seidel, N., Doren, S., Sellers, S., Cline, A., Metzger, M., Agricola, B., Donahue, R., and Bodine, D. Improved retroviral transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony stimulating factor. Proc. Nat. Acad. Sci. USA, 93: 11871-11876, 1996.
41. Lyman, S. D., James, L., Vanden Bos, T., de Vries, P., Brasel, K., Gliniak, B., Hollingsworth, L. T., Picha, K. S., McKenna, H. J., Splett, R. R., et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell, 75: 1157-1167, 1993.
42. Haylock, D. N., Horsfall, M. J., Dowes, T. L., Ramshaw, H. S., Niutta, S., Protopsaltis, S., Peng, L., Burrel, C., Rappold, I., Buhring, H. J., and Simmons, P. J. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood, 90: 2260-2272, 1997.
43. Moritz, T., Patel, V. P., and Williams, D. A. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J. Clin. Invest., 93: 1451-1457, 1994.
44. Kiem, H., Heyward, P. Winkler, S., Potter, Allen, J., Miller, M. D., Andrews, D. A. Miller, A. D. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood, 90: 4638-4645, 1997.
45. Kiem, H., Andrews, P., Morris, R. G., Peterson, J., Heyward, L., Allen, S., Rasko, J. M., Potter, J. E., and Miller, A. D. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6. stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood, 92: 1878-1886, 1998.